Literature DB >> 8546671

Dual bradykinin B2 receptor signalling in A431 human epidermoid carcinoma cells: activation of protein kinase C is counteracted by a GS-mediated stimulation of the cyclic AMP pathway.

C Liebmann1, A Graness, B Ludwig, A Adomeit, A Boehmer, F D Boehmer, B Nürnberg, R Wetzker.   

Abstract

Cell membranes of the human epidermoid cell line A431 express classical bradykinin (BK) B2 receptors, as assessed by [3H]BK binding studies. Furthermore, stimulation by BK induced a time-dependent modulation of protein kinase C (PKC) activity in A431 cells: a rapid activation (t1/2 approximately 1 min) is followed by a slow inhibition (t1/2 approximately 20 min) of PKC translocation measured by [3H]phorbol 12,13-dibutyrate binding. In addition, BK stimulated both adenylate cyclase activity in A431 membranes and accumulation of intracellular cyclic AMP (cAMP) in intact cells in a retarded manner. A possible BK-induced activation of the cAMP pathway mediated via PKC, phospholipase D, prostaglandins or Ca2+/calmodulin was excluded. A 35 kDa protein was found in A431 membranes to be specifically phosphorylated in the presence of both BK and protein kinase A (PKA). An anti-alpha s-antibody, AS 348, abolished stimulation of adenylate cyclase activity in response to BK, cholera toxin and isoprenaline, strongly suggesting the involvement of Gs proteins in the BK action. The BK-activated cAMP signalling system might be important for the observed inactivation of PKC slowly evoked by BK: the BK-induced rapid activation of PKC is decreased by dibutyryl cAMP, and the slow inhibition of PKC is prevented by an inhibitor of PKA, adenosine 3':5'-monophosphothioate (cyclic, Rp isomer). The inhibition of PKC translocation might be exerted directly at the level of PKC activation, since stimulation of phosphoinositide hydrolysis by BK was affected by neither dibutyryl cAMP nor forskolin. Thus our results provide the first evidence that A431 cells BK is able to activate two independent signal-transduction pathways via a single class of B2 receptors but two different G proteins. The lagging stimulation of the cAMP signalling pathway via Gs might serve to switch off PKC, which is rapidly activated via Gq-mediated stimulation of phosphoinositide hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546671      PMCID: PMC1216870          DOI: 10.1042/bj3130109

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  cAMP abrogates the p21ras-mitogen-activated protein kinase pathway in fibroblasts.

Authors:  P L Hordijk; I Verlaan; K Jalink; E J van Corven; W H Moolenaar
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

Review 2.  Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases.

Authors:  R Iyengar
Journal:  FASEB J       Date:  1993-06       Impact factor: 5.191

3.  Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases.

Authors:  R Taussig; W J Tang; J R Hepler; A G Gilman
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

4.  G12 and G13 alpha-subunits are immunochemically detectable in most membranes of various mammalian cells and tissues.

Authors:  K Spicher; F Kalkbrenner; A Zobel; R Harhammer; B Nürnberg; A Söling; G Schultz
Journal:  Biochem Biophys Res Commun       Date:  1994-02-15       Impact factor: 3.575

5.  Purification of a novel G-protein alpha 0-subtype from mammalian brain.

Authors:  B Nürnberg; K Spicher; R Harhammer; A Bosserhoff; R Frank; H Hilz; G Schultz
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

6.  Differential pharmacology of cloned human and mouse B2 bradykinin receptors.

Authors:  J F Hess; J A Borkowski; T Macneil; G Y Stonesifer; J Fraher; C D Strader; R W Ransom
Journal:  Mol Pharmacol       Date:  1994-01       Impact factor: 4.436

7.  Bradykinin-stimulated transient modulation of epidermal growth factor receptors in A-431 human epidermoid carcinoma cells.

Authors:  K Hosoi; K Kurihara; T Ueha
Journal:  J Cell Physiol       Date:  1993-10       Impact factor: 6.384

8.  Stimulation of rat parietal cell function by histamine and GLP-1-(7-36) amide is mediated by Gs alpha.

Authors:  J Schmidtler; K Dehne; S Offermanns; W Rosenthal; M Classen; W Schepp
Journal:  Am J Physiol       Date:  1994-05

9.  Protein kinase C-dependent cyclic AMP formation in airway smooth muscle: the role of type II adenylate cyclase and the blockade of extracellular-signal-regulated kinase-2 (ERK-2) activation.

Authors:  N J Pyne; N Moughal; P A Stevens; D Tolan; S Pyne
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

10.  Regulation of the MAP kinase cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP.

Authors:  P Peraldi; M Frödin; J V Barnier; V Calleja; J C Scimeca; C Filloux; G Calothy; E Van Obberghen
Journal:  FEBS Lett       Date:  1995-01-09       Impact factor: 4.124

View more
  20 in total

1.  Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation.

Authors:  A Adomeit; A Graness; S Gross; K Seedorf; R Wetzker; C Liebmann
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Resonant waveguide grating biosensor for living cell sensing.

Authors:  Ye Fang; Ann M Ferrie; Norman H Fontaine; John Mauro; Jitendra Balakrishnan
Journal:  Biophys J       Date:  2006-06-09       Impact factor: 4.033

3.  Bradykinin stimulates interleukin-8 production by human lung fibroblasts.

Authors:  R Hayashi; N Yamashita; S Matsui; M Maruyama; E Sugiyama; S Sugiyama; M Kobayashi
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

Review 4.  Involvement of bradykinin in brain edema development after ischemic stroke.

Authors:  Marina Dobrivojević; Katarina Špiranec; Aleksandra Sinđić
Journal:  Pflugers Arch       Date:  2014-04-23       Impact factor: 3.657

5.  Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells.

Authors:  A Graness; S Hanke; F D Boehmer; P Presek; C Liebmann
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

6.  Bradykinin shifts endothelial fluid passage from para- to transcellular routes.

Authors:  C Riethmüller; P Jungmann; J Wegener; H Oberleithner
Journal:  Pflugers Arch       Date:  2006-09-19       Impact factor: 3.657

7.  Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.

Authors:  J L Paquet; J M Luccarini; C Fouchet; E Defrêne; B Loillier; C Robert; P Bélichard; B Cremers; D Pruneau
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

8.  G protein-coupled receptor-mediated mitogen-activated protein kinase activation through cooperation of Galpha(q) and Galpha(i) signals.

Authors:  A Blaukat; A Barac; M J Cross; S Offermanns; I Dikic
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

9.  Bradykinin promotes neuron-generating division of neural progenitor cells through ERK activation.

Authors:  Micheli M Pillat; Claudiana Lameu; Cleber A Trujillo; Talita Glaser; Angélica R Cappellari; Priscilla D Negraes; Ana M O Battastini; Telma T Schwindt; Alysson R Muotri; Henning Ulrich
Journal:  J Cell Sci       Date:  2016-08-15       Impact factor: 5.285

Review 10.  Excitation and sensitization of nociceptors by bradykinin: what do we know?

Authors:  Kazue Mizumura; Takeshi Sugiura; Kimiaki Katanosaka; Ratan K Banik; Yasuko Kozaki
Journal:  Exp Brain Res       Date:  2009-04-26       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.